| Year |
Citation |
Score |
| 2019 |
Guarino VR, Olson RE, Everlof JG, Wang N, McDonald I, Haskell R, Clarke W, Lentz KA. An amide-based sulfenamide prodrug of gamma secretase inhibitor BMS-708163 delivers parent drug from an oral conventional solid dosage form in male beagle dog. Bioorganic & Medicinal Chemistry Letters. 126856. PMID 31870650 DOI: 10.1016/J.Bmcl.2019.126856 |
0.384 |
|
| 2019 |
Boy KM, Guernon JM, Zuev DS, Xu L, Zhang Y, Shi J, Marcin LR, Higgins MA, Wu YJ, Krishnananthan S, Li J, Trehan A, Smith D, Toyn JH, Meredith JE, ... ... Lentz KA, et al. Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481. Acs Medicinal Chemistry Letters. 10: 312-317. PMID 30891132 DOI: 10.1021/Acsmedchemlett.8B00541 |
0.356 |
|
| 2018 |
Onorato JM, Xu C, Chen XQ, Rose AV, Generaux C, Lentz K, Shipkova P, Arthur S, Hennan JK, Haskell R, Myers MC, Lawrence RM, Finlay HJ, Basso M, Bostwick J, et al. Linking (Pyr)apelin-13 pharmacokinetics to efficacy: Stabilization and measurement of a high clearance peptide in rodents. Analytical Biochemistry. PMID 30605634 DOI: 10.1016/J.Ab.2018.12.022 |
0.329 |
|
| 2017 |
Narang AS, Balakrishnan A, Morrison J, Li J, Wang J, Gu H, Taylor K, Santone K, Ehrmann J, Beyer S, Lu X, Ketner R, Pizzano J, Orcutt T, Shields E, ... ... Lentz K, et al. Role of Regional Absorption and Gastrointestinal Motility on Variability in Oral Drug Absorption of a Model Drug. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 28455207 DOI: 10.1016/J.Ejpb.2017.04.026 |
0.354 |
|
| 2017 |
Martinez MN, Mistry B, Lukacova V, Lentz KA, Polli JE, Hoag SW, Dowling T, Kona R, Fahmy RM. Exploring Canine-Human Differences in Product Performance. Part II: Use of Modeling and Simulation to Explore the Impact of Formulation on Ciprofloxacin In Vivo Absorption and Dissolution in Dogs. The Aaps Journal. PMID 28265981 DOI: 10.1208/S12248-017-0055-Y |
0.537 |
|
| 2016 |
Soares HD, Gasior M, Toyn JH, Wang JS, Hong Q, Berisha F, Furlong MT, Raybon J, Lentz KA, Sweeney F, Zheng N, Akinsanya B, Berman RM, Thompson LA, Olson RE, et al. The Gamma Secretase Modulator, BMS-932481, Modulates Aβ Peptides in the Plasma and CSF of Healthy Volunteers. The Journal of Pharmacology and Experimental Therapeutics. PMID 27189973 DOI: 10.1124/Jpet.116.232256 |
0.311 |
|
| 2016 |
Ahuja VT, Hartz RA, Molski TF, Mattson GK, Lentz KA, Grace JE, Lodge NJ, Bronson JJ, Macor JE. Synthesis and evaluation of carbamate and aryl ether substituted pyrazinones as corticotropin releasing factor-1 (CRF1) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. PMID 27020524 DOI: 10.1016/J.Bmcl.2016.03.067 |
0.318 |
|
| 2015 |
Boy KM, Guernon JM, Wu YJ, Zhang Y, Shi J, Zhai W, Zhu S, Gerritz SW, Toyn JH, Meredith JE, Barten DM, Burton CR, Albright CF, Good AC, Grace JE, ... Lentz KA, et al. Macrocyclic prolinyl acyl guanidines as inhibitors of β-secretase (BACE). Bioorganic & Medicinal Chemistry Letters. PMID 26497283 DOI: 10.1016/J.Bmcl.2015.10.031 |
0.336 |
|
| 2015 |
Baumgart BR, Van Vleet TR, Simic D, Salcedo TW, Lentz K, Donegan M, Davies MH, Bunch RT, Sanderson TP, Lange RW. D-α-tocopheryl polyethylene glycol 1000 succinate-containing vehicles provide no detectable chemoprotection from oxidative damage. Journal of Applied Toxicology : Jat. 35: 791-8. PMID 25348750 DOI: 10.1002/Jat.3072 |
0.328 |
|
| 2014 |
Toyn JH, Thompson LA, Lentz KA, Meredith JE, Burton CR, Sankaranararyanan S, Guss V, Hall T, Iben LG, Krause CM, Krause R, Lin XA, Pierdomenico M, Polson C, Robertson AS, et al. Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780. International Journal of Alzheimer's Disease. 2014: 431858. PMID 25097793 DOI: 10.1155/2014/431858 |
0.354 |
|
| 2014 |
Hu S, Huang Y, Wu YJ, He H, Grant-Young KA, Bertekap RL, Whiterock V, Brassil P, Lentz K, Sivaprakasam P, Langley DR, Westphal RS, Scola PM. Structure activity relationship studies of 3-arylsulfonyl-pyrido[1,2-a]pyrimidin-4-imines as potent 5-HT₆ antagonists. Bioorganic & Medicinal Chemistry. 22: 1782-90. PMID 24495863 DOI: 10.1016/J.Bmc.2014.01.003 |
0.36 |
|
| 2013 |
Vivian D, Cheng K, Khurana S, Xu S, Whiterock V, Witter D, Lentz KA, Santone KS, Raufman JP, Polli JE. Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile Acid transporter activity. Pharmaceutical Research. 30: 1240-51. PMID 23319170 DOI: 10.1007/S11095-012-0963-6 |
0.595 |
|
| 2013 |
Albright CF, Dockens RC, Meredith JE, Olson RE, Slemmon R, Lentz KA, Wang JS, Denton RR, Pilcher G, Rhyne PW, Raybon JJ, Barten DM, Burton C, Toyn JH, Sankaranarayanan S, et al. Pharmacodynamics of selective inhibition of γ-secretase by avagacestat. The Journal of Pharmacology and Experimental Therapeutics. 344: 686-95. PMID 23275065 DOI: 10.1124/Jpet.112.199356 |
0.33 |
|
| 2012 |
Luo G, Chen L, Conway CM, Denton R, Keavy D, Gulianello M, Huang Y, Kostich W, Lentz KA, Mercer SE, Schartman R, Signor L, Browning M, Macor JE, Dubowchik GM. Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of Migraine. Acs Medicinal Chemistry Letters. 3: 337-41. PMID 24900474 DOI: 10.1021/Ml300021S |
0.392 |
|
| 2012 |
Luo G, Chen L, Conway CM, Denton R, Keavy D, Signor L, Kostich W, Lentz KA, Santone KS, Schartman R, Browning M, Tong G, Houston JG, Dubowchik GM, Macor JE. Discovery of (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): an oral calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraine. Journal of Medicinal Chemistry. 55: 10644-51. PMID 23153230 DOI: 10.1021/Jm3013147 |
0.349 |
|
| 2012 |
Gerritz SW, Zhai W, Shi S, Zhu S, Toyn JH, Meredith JE, Iben LG, Burton CR, Albright CF, Good AC, Tebben AJ, Muckelbauer JK, Camac DM, Metzler W, Cook LS, ... ... Lentz KA, et al. Acyl guanidine inhibitors of β-secretase (BACE-1): optimization of a micromolar hit to a nanomolar lead via iterative solid- and solution-phase library synthesis. Journal of Medicinal Chemistry. 55: 9208-23. PMID 23030502 DOI: 10.1021/Jm300931Y |
0.335 |
|
| 2012 |
Whiterock VJ, Morgan DG, Lentz KA, Orcutt TL, Sinz MW. Phenacetin pharmacokinetics in CYP1A2-deficient beagle dogs Drug Metabolism and Disposition. 40: 228-231. PMID 22074769 DOI: 10.1124/Dmd.111.041848 |
0.308 |
|
| 2011 |
Thompson LA, Shi J, Decicco CP, Tebben AJ, Olson RE, Boy KM, Guernon JM, Good AC, Liauw A, Zheng C, Copeland RA, Combs AP, Trainor GL, Camac DM, Muckelbauer JK, ... Lentz KA, et al. Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21: 6909-15. PMID 21974952 DOI: 10.1016/J.Bmcl.2011.06.116 |
0.342 |
|
| 2011 |
Boy KM, Guernon JM, Shi J, Toyn JH, Meredith JE, Barten DM, Burton CR, Albright CF, Marcinkeviciene J, Good AC, Tebben AJ, Muckelbauer JK, Camac DM, Lentz KA, Bronson JJ, et al. Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE). Bioorganic & Medicinal Chemistry Letters. 21: 6916-24. PMID 21782431 DOI: 10.1016/J.Bmcl.2011.06.109 |
0.332 |
|
| 2011 |
Marcin LR, Higgins MA, Zusi FC, Zhang Y, Dee MF, Parker MF, Muckelbauer JK, Camac DM, Morin PE, Ramamurthy V, Tebben AJ, Lentz KA, Grace JE, Marcinkeviciene JA, Kopcho LM, et al. Synthesis and SAR of indole-and 7-azaindole-1,3-dicarboxamide hydroxyethylamine inhibitors of BACE-1. Bioorganic & Medicinal Chemistry Letters. 21: 537-41. PMID 21078556 DOI: 10.1016/J.Bmcl.2010.10.079 |
0.363 |
|
| 2010 |
Gillman KW, Starrett JE, Parker MF, Xie K, Bronson JJ, Marcin LR, McElhone KE, Bergstrom CP, Mate RA, Williams R, Meredith JE, Burton CR, Barten DM, Toyn JH, Roberts SB, ... Lentz KA, et al. Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor. Acs Medicinal Chemistry Letters. 1: 120-4. PMID 24900185 DOI: 10.1021/Ml1000239 |
0.382 |
|
| 2009 |
Hartz RA, Ahuja VT, Zhuo X, Mattson RJ, Denhart DJ, Deskus JA, Vrudhula VM, Pan S, Ditta JL, Shu YZ, Grace JE, Lentz KA, Lelas S, Li YW, Molski TF, et al. A strategy to minimize reactive metabolite formation: discovery of (S)-4-(1-cyclopropyl-2-methoxyethyl)-6-[6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino]-5-oxo-4,5-dihydropyrazine-2-carbonitrile as a potent, orally bioavailable corticotropin-releasing factor-1 receptor antagonist. Journal of Medicinal Chemistry. 52: 7653-68. PMID 19954247 DOI: 10.1021/Jm900716V |
0.399 |
|
| 2009 |
Hartz RA, Ahuja VT, Arvanitis AG, Rafalski M, Yue EW, Denhart DJ, Schmitz WD, Ditta JL, Deskus JA, Brenner AB, Hobbs FW, Payne J, Lelas S, Li YW, Molski TF, ... ... Lentz KA, et al. Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists. Journal of Medicinal Chemistry. 52: 4173-91. PMID 19552437 DOI: 10.1021/Jm900301Y |
0.356 |
|
| 2009 |
Hartz RA, Ahuja VT, Rafalski M, Schmitz WD, Brenner AB, Denhart DJ, Ditta JL, Deskus JA, Yue EW, Arvanitis AG, Lelas S, Li YW, Molski TF, Wong H, Grace JE, ... Lentz KA, et al. In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. Journal of Medicinal Chemistry. 52: 4161-72. PMID 19552436 DOI: 10.1021/Jm900302Q |
0.361 |
|
| 2008 |
Lentz KA. Current methods for predicting human food effect. The Aaps Journal. 10: 282-8. PMID 18500565 DOI: 10.1208/S12248-008-9025-8 |
0.311 |
|
| 2008 |
Meredith JE, Thompson LA, Toyn JH, Marcin L, Barten DM, Marcinkeviciene J, Kopcho L, Kim Y, Lin A, Guss V, Burton C, Iben L, Polson C, Cantone J, Ford M, ... ... Lentz KA, et al. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice. The Journal of Pharmacology and Experimental Therapeutics. 326: 502-13. PMID 18499745 DOI: 10.1124/Jpet.108.138974 |
0.313 |
|
| 2004 |
Tolle-Sander S, Lentz KA, Maeda DY, Coop A, Polli JE. Increased acyclovir oral bioavailability via a bile acid conjugate. Molecular Pharmaceutics. 1: 40-8. PMID 15832499 DOI: 10.1021/Mp034010T |
0.565 |
|
| 2000 |
Lentz KA, Polli JW, Wring SA, Humphreys JE, Polli JE. Influence of passive permeability on apparent P-glycoprotein kinetics. Pharmaceutical Research. 17: 1456-60. PMID 11303953 DOI: 10.1023/A:1007692622216 |
0.472 |
|
| 2000 |
Lentz KA, Hayashi J, Lucisano LJ, Polli JE. Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system. International Journal of Pharmaceutics. 200: 41-51. PMID 10845684 DOI: 10.1016/S0378-5173(00)00334-3 |
0.482 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2007 |
Gu CH, Li H, Levons J, Lentz K, Gandhi RB, Raghavan K, Smith RL. Predicting effect of food on extent of drug absorption based on physicochemical properties. Pharmaceutical Research. 24: 1118-30. PMID 17385020 DOI: 10.1007/S11095-007-9236-1 |
0.299 |
|
| 2005 |
Rytting E, Lentz KA, Chen XQ, Qian F, Vakatesh S. Aqueous and cosolvent solubility data for drug-like organic compounds. The Aaps Journal. 7: E78-105. PMID 16146352 DOI: 10.1208/Aapsj070110 |
0.298 |
|
| 2010 |
Meredith J, Barten D, Burton C, Corsa J, Fiedler T, Guss V, Polson C, Seiffert D, Car B, Detnon RR, Hanumegowda U, Lentz K, Clarke W, Macor J, Zaczek R, et al. Separation of Aβ Reduction from Notch Toxicity with Gamma Secretase Inhibitors in Rats Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.08.080 |
0.293 |
|
| 2016 |
Kostich W, Hamman BD, Li YW, Naidu S, Dandapani K, Feng J, Easton A, Bourin C, Baker K, Allen J, Savelieva K, Louis JV, Dokania M, Elavazhangan S, Vattikundala P, ... ... Lentz KA, et al. Inhibition of AAK1 kinase as a novel therapeutic approach to treat neuropathic pain. The Journal of Pharmacology and Experimental Therapeutics. PMID 27411717 DOI: 10.1124/Jpet.116.235333 |
0.288 |
|
| 2007 |
Lentz KA, Quitko M, Morgan DG, Grace JE, Gleason C, Marathe PH. Development and validation of a preclinical food effect model. Journal of Pharmaceutical Sciences. 96: 459-72. PMID 17075867 DOI: 10.1002/Jps.20767 |
0.288 |
|
| 2016 |
Cook J, Zusi FC, McDonald IM, King D, Hill MD, Iwuagwu C, Mate RA, Fang H, Zhao R, Wang B, Cutrone J, Ma B, Gao Q, Knox RJ, Matchett M, ... ... Lentz K, et al. Design and Synthesis of a New Series of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity Relationship. Journal of Medicinal Chemistry. PMID 27958732 DOI: 10.1021/Acs.Jmedchem.6B01506 |
0.286 |
|
| 2017 |
Hill MD, Fang H, King HD, Iwuagwu CI, McDonald IM, Cook J, Zusi FC, Mate RA, Knox RJ, Post-Munson D, Easton A, Miller R, Lentz K, Clarke W, Benitex Y, et al. Development of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor Agonists. Acs Medicinal Chemistry Letters. 8: 133-137. PMID 28105289 DOI: 10.1021/Acsmedchemlett.6B00471 |
0.281 |
|
| 2004 |
Rytting E, Lentz KA, Chen XQ, Qian F, Venkatesh S. A quantitative structure-property relationship for predicting drug solubility in PEG 400/water cosolvent systems. Pharmaceutical Research. 21: 237-44. PMID 15032304 DOI: 10.1023/B:Pham.0000016237.06815.7A |
0.273 |
|
| 2009 |
Hartz RA, Ahuja VT, Rafalski M, Schmitz WD, Brenner AB, Denhart DJ, Ditta JL, Deskus JA, Yue EW, Arvanitis AG, Lelas S, Li YW, Molski TF, Wong H, Grace JE, ... Lentz KA, et al. Corrections to in vitro intrinsic clearance-based optimization of N 3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF 1) receptor antagonists (Journal of Medicinal Chemistry (2009) 52, (4161-4172) DOI: 10.1021/jm900302q] Journal of Medicinal Chemistry. 52: 5770. DOI: 10.1021/Jm9011033 |
0.265 |
|
| 2015 |
Shi J, Zuev D, Xu L, Lentz KA, Grace JE, Toyn JH, Olson RE, Macor JE, Thompson LA. Design and optimization of tricyclic gamma-secretase modulators. Bioorganic & Medicinal Chemistry Letters. PMID 26848108 DOI: 10.1016/J.Bmcl.2015.06.020 |
0.265 |
|
| 2023 |
Zhuo X, Howell BA, Shen H, Woodhead JL, Mosure K, Zhang Y, Scialis RJ, Iyer R, Sun Y, Boy KM, Lentz KA, Denton R, Soars MG, Johnson BM, Humphreys WG. Mechanistic Investigation of Liver Injury Induced by BMS-932481, an Experimental ɣ-Secretase Modulator. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 37261863 DOI: 10.1093/toxsci/kfad057 |
0.25 |
|
| 2017 |
King D, Iwuagwu C, Cook J, McDonald IM, Mate R, Zusi FC, Hill MD, Fang H, Zhao R, Wang B, Easton AE, Miller R, Post-Munson D, Knox RJ, Gallagher L, ... ... Lentz KA, et al. BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia. Acs Medicinal Chemistry Letters. 8: 366-371. PMID 28337332 DOI: 10.1021/Acsmedchemlett.7B00032 |
0.249 |
|
| 2013 |
Lentz K, Raybon J, Sinz MW. Drug Metabolism and Pharmacokinetics in Drug Discovery Drug Discovery: Practices, Processes, and Perspectives. 99-139. DOI: 10.1002/9781118354483.ch4 |
0.246 |
|
| 2021 |
Cheng PTW, Kaltenbach RF, Zhang H, Shi J, Tao S, Li J, Kennedy LJ, Walker SJ, Shi Y, Wang Y, Dhanusu S, Reddigunta R, Kumaravel S, Jusuf S, Smith D, ... ... Lentz KA, et al. Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases. Journal of Medicinal Chemistry. PMID 34709814 DOI: 10.1021/acs.jmedchem.1c01256 |
0.217 |
|
| 2016 |
Toyn JH, Boy KM, Raybon J, Meredith JE, Roberston AS, Guss V, Hoque N, Sweeney F, Zhuo X, Clarke W, Snow K, Denton RR, Zuev D, Thompson LA, Morrison J, ... ... Lentz KA, et al. Robust translation of GSM pharmacology across preclinical species and human subjects. The Journal of Pharmacology and Experimental Therapeutics. PMID 27189974 DOI: 10.1124/Jpet.116.232249 |
0.198 |
|
| 2022 |
Cheng D, Zinker BA, Luo Y, Shipkova P, De Oliveira CH, Krishna G, Brown EA, Boehm SL, Tirucherai GS, Gu H, Ma Z, Chu CH, Onorato JM, Kopcho LM, Ammar R, ... ... Lentz KA, et al. MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity. Cell Metabolism. 34: 1732-1748.e5. PMID 36323235 DOI: 10.1016/j.cmet.2022.10.007 |
0.192 |
|
| 2008 |
Gu CH, Li H, Levons J, Lentz K, Gandhi RB, Raghavan K, Smith RL. Predicting effect of food on extent of drug absorption based on physicochemical properties (Pharmaceutical Research (2007) DOI: 10.1007/s11095-007-9236-1) Pharmaceutical Research. 25: 979. DOI: 10.1007/s11095-007-9337-x |
0.145 |
|
| 2023 |
Dzierba CD, Dasgupta B, Karageorge G, Kostich W, Hamman B, Allen J, Esposito KM, Padmanabha R, Grace J, Lentz K, Morrison J, Morgan D, Easton A, Bourin C, Browning MR, et al. Discovery of pyrrolo[2,1-][1,2,4]triazine-based inhibitors of adaptor protein 2-associated kinase 1 for the treatment of pain. Medicinal Chemistry Research : An International Journal For Rapid Communications On Design and Mechanisms of Action of Biologically Active Agents. 1-7. PMID 37362320 DOI: 10.1007/s00044-023-03079-x |
0.129 |
|
| 2006 |
Gupta E, Barends DM, Yamashita E, Lentz KA, Harmsze AM, Shah VP, Dressman JB, Lipper RA. Review of global regulations concerning biowaivers for immediate release solid oral dosage forms European Journal of Pharmaceutical Sciences. 29: 315-324. PMID 16806858 DOI: 10.1016/j.ejps.2006.05.001 |
0.091 |
|
| 1996 |
Nunez D, Wester JD, Lentz KA, Amendola MA. Helical computed tomography of liver injuries: A trial of dual phase imaging Emergency Radiology. 3: 20-24. DOI: 10.1007/BF01508161 |
0.069 |
|
| 1996 |
Lentz KA, McKenney MG, Nunez JDB, Martin L. Evaluating blunt abdominal trauma: Role for ultrasonography Journal of Ultrasound in Medicine. 15: 447-451. PMID 8738989 DOI: 10.7863/jum.1996.15.6.447 |
0.063 |
|
| 1996 |
Lentz KA, McKenney MG. Quantitative sensitivity of ultrasound in detecting free intraperitoneal fluid The Journal of Trauma. 40: 1052-1054. PMID 8656466 |
0.056 |
|
| 1999 |
Lentz KA. Effects of intraspecific competition and nutrient supply on the endangered northeastern bulrush, Scirpus ancistrochaetus schuyler (Cyperaceae) American Midland Naturalist. 142: 47-54. |
0.054 |
|
| 1999 |
Lentz KA, Dunson WA. Distinguishing characteristics of temporary pond habitat of endangered Northeastern Bulrush, Scirpus ancistrochaetus Wetlands. 19: 162-167. |
0.048 |
|
| 1998 |
Lentz KA, Dunson WA. Water level affects growth of endangered northeastern bulrush, Scirpus ancistrochaetus Schuyler Aquatic Botany. 60: 213-219. DOI: 10.1016/S0304-3770(97)00098-3 |
0.047 |
|
| 1985 |
Lentz KA. The expressed fears of young children Child Psychiatry &Amp; Human Development. 16: 3-13. PMID 4064789 DOI: 10.1007/BF00707766 |
0.037 |
|
| 1998 |
Lentz KA, Johnson HA. Factors affecting germination of endangered northeastern bulrush, Scirpus ancistrochaetus Schuyler (Cyperaceae) Seed Science and Technology. 26: 733-741. |
0.036 |
|
| 1998 |
Lentz KA, Cipollini DF. Effect of light and simulated herbivory on growth of endangered northeastern bulrush, Scirpus ancistrochaetus Schuyler Plant Ecology. 139: 125-131. DOI: 10.1023/A:1009762603019 |
0.032 |
|
| 1994 |
Nuñez DB, Ahmad AA, Coin CG, LeBlang S, Becerra JL, Henry R, Lentz K, Quencer RM. Clearing the cervical spine in multiple trauma victims: A time-effective protocol using helical computed tomography Emergency Radiology. 1: 273-278. DOI: 10.1007/BF02614949 |
0.022 |
|
| Hide low-probability matches. |